Cargando…
Chloride intracellular channel protein 2: prognostic marker and correlation with PD-1/PD-L1 in breast cancer
Immune checkpoint inhibition has emerged as an effective treatment for multiple solid tumors, including advanced-stage breast cancer (BC). During the past decade, the US Food and Drug Administration has approved a number of agents for immune checkpoint blockade (ICB). However, the limited data on mo...
Autores principales: | Xu, Tao, Wang, Zhi, Dong, Menglu, Wu, Di, Liao, Shujie, Li, Xingrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521498/ https://www.ncbi.nlm.nih.gov/pubmed/32915772 http://dx.doi.org/10.18632/aging.103712 |
Ejemplares similares
-
The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
por: Chen, Li, et al.
Publicado: (2022) -
ITM2A as a Tumor Suppressor and Its Correlation With PD-L1 in Breast Cancer
por: Zhang, Rui, et al.
Publicado: (2021) -
The intracellular signalosome of PD-L1 in cancer cells
por: Escors, David, et al.
Publicado: (2018) -
GLUT1 as a Prognostic Factor for Classical Hodgkin’s Lymphoma: Correlation with PD-L1 and PD-L2 Expression
por: Koh, Young Wha, et al.
Publicado: (2017) -
Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer
por: Jiang, Siqing, et al.
Publicado: (2022)